Skip to main content
Log in

Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Aim

To determine the frequency of occurrence, risk factors, clinical spectrum and drugs associated with adverse drug reactions (ADRs) occurring in the coronary care unit (CCU) of a tertiary care hospital.

Methods

This was a retrospective cohort study based on evaluation of the medical records of consecutive patients admitted to the CCU between January 2008 and December 2008. Each prescription was monitored for ADRs, and each ADR was assessed for causality, severity, predictability and preventability by two physicians using relevant scales. The chi-square test and independent t test were used to compare the ADR and non-ADR groups. Multiple binary logistic regression was used to identify risk factors for developing ADRs in the CCU.

Results

Of 595 patients, 152 (25.5%) developed ADRs, of which 45% were potentially preventable. Severe ADRs constituted 28.6% of the total ADRs. Patients who developed an ADR had a longer duration of stay in the hospital (2.8 extra days) (p < 0.05). Hypokalemia/hyperkalemia (22%), bleeding (11%) and cardiac arrhythmias (11%) were the commonest ADRs. The highest rates of ADRs were seen with streptokinase (59.4%). The predictors for developing an ADR in the CCU included renal dysfunction [odds ratio (OR) 1.66, 95% confidence interval (CI) 1.007–2.72], arrhythmias (OR 1.74, 95% CI 1.052–2.87) and polypharmacy with more than ten drugs (OR 11.3, 95% CI 1.45–87.44).

Conclusion

A high frequency of ADR occurrence was identified, with many of the ADRs being potentially preventable. Patients with renal dysfunction or cardiac arrhythmias and those receiving polypharmacy were at an increased risk for developing an ADR in the CCU.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

ADE:

Adverse drug event

ADR:

Adverse drug reactions

CCU:

Coronary care unit

IERB:

Institutional Ethical Review Board

References

  1. Krahenbuhl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krahenbuhl S (2007) Drug-related problems in hospitals: a review of the recent literature. Drug Saf 30(5):379–407

    Article  PubMed  Google Scholar 

  2. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15):1200–1205

    Article  PubMed  CAS  Google Scholar 

  3. Wester K, Jonsson AK, Spigset O, Druid H, Hagg S (2008) Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 65(4):573–579

    Article  PubMed  Google Scholar 

  4. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA et al (1997) The costs of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA 277(4):307–311

    Article  PubMed  CAS  Google Scholar 

  5. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277(4):301–306

    Article  PubMed  CAS  Google Scholar 

  6. Wroblewski HA, Tisdale JE, Overhaolser BR, Joanna R. Adverse drug events resulting in admissions to a cardiac care unit. J Am Coll Cardiol 2010;(55).

  7. Davies EC, Green CF, Mottram DR, Pirmohamed M (2007) Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2(1):79–87

    Article  PubMed  Google Scholar 

  8. Mohebbi N, Shalviri G, Salarifar M, Salamzadeh J, Gholami K (2010) Adverse drug reactions induced by cardiovascular drugs in cardiovascular care unit patients. Pharmacoepidemiol Drug Saf 19(9):889–894

    Article  PubMed  Google Scholar 

  9. World Health Organization (1972) International drug monitoring—the role of national centers. Technical Report No. 498. World Health Organization, Geneva

  10. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239–245

    Article  PubMed  CAS  Google Scholar 

  11. Schumock GT, Thornton JP (1992) Focusing on the preventability of adverse drug reactions. Hosp Pharm 27(6):538

    PubMed  CAS  Google Scholar 

  12. Hartwig SC, Siegel J, Schneider PJ (1992) Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 49(9):2229–2232

    PubMed  CAS  Google Scholar 

  13. Fahimi F, Baniasadi S (2008) Adverse drug reactions in the post coronary care unit inpatients of a teaching hospital. Iranian J Pharm Res 7:223–228

    Google Scholar 

  14. Joshua L, Devi P, Guido S (2009) Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiol Drug Saf 18(7):639–645

    Article  PubMed  Google Scholar 

  15. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D et al (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE prevention study group. JAMA 274(1):29–34

    Article  PubMed  CAS  Google Scholar 

  16. Winterstein AG, Sauer BC, Hepler CD, Poole C (2002) Preventable drug-related hospital admissions. Ann Pharmacother 36(7–8):1238–1248

    Article  PubMed  Google Scholar 

  17. Routledge PA, O'Mahony MS, Woodhouse KW (2003) Adverse drug reactions in elderly patients. Br J Clin Pharmacol 57:121–126

    Article  Google Scholar 

  18. Venulet J, ten Harn M (1996) Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther 34(3):112–129

    PubMed  CAS  Google Scholar 

  19. Rahim SA, Mody A, Pickering J, Devereaux PJ, Yusuf S (2010) Iatrogenic adverse events in the coronary care unit. Circ Cardiovasc Qual Outcomes 2:437–442

    Article  Google Scholar 

Download references

Acknowledgments

The authors sincerely and gratefully acknowledge the time, cooperation and effort of the personnel at the medical records department of St. John’s Hospital, Bangalore and the indispensable contribution of Mrs. Sumitra, statistician at St. John’s Research Institute, Bangalore. We also thank Ms. Sandra Sarah, final year medical student, for her contribution to aspects of data entry and the construction of tables and graphs.

Potential conflict of interest

NIL

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deepak Y. Kamath.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Devi, P., Kamath, D.Y., Anthony, N. et al. Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital. Eur J Clin Pharmacol 68, 427–433 (2012). https://doi.org/10.1007/s00228-011-1138-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-011-1138-9

Keywords

Navigation